GGrantIndex
← Leaderboards

Abbas E. Kitabchi

University Of Tennessee Health Sci Ctr

Google Scholar ↗PubMed ↗ORCID ↗
$15,006,255
Attributed
$15,006,255
Total exposure
13
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY2005–13
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$15,006,255 · 13

By mechanism

U01$12,214,577 · 2
M01$1,803,633 · 10
R01$988,045 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Tennessee Health Sci Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Human Subject”

Research focus

Human SubjectHuman Therapy EvaluationNoninsulin Dependent Diabetes MellitusClinical ResearchExerciseClinical TrialsObesityDiabetes Mellitus TherapyCooperative StudyNutrition Related TagDisease /Disorder Proneness /RiskMetforminDisease /Disorder Prevention /ControlComputed Axial TomographyOutcomes ResearchDietWeight LossDiabetes MellitusCardiovascular Disorder RiskPlacebosDiet TherapyBody CompositionGlucose ToleranceChemotherapy

Grant awards (38)

Diabetes Prevention Program Outcomes Study-Phase 2$558,403
U01 · FY2013 · DK · contact PI
Diabetes Prevention Program Outcomes Study-Phase 2$568,722
U01 · FY2012 · DK · contact PI
Diabetes Prevention Program Outcomes Study-Phase 2$436,437
U01 · FY2011 · DK · contact PI
Diabetes Prevention Program Outcomes Study-Phase 2$510,437
U01 · FY2010 · DK · contact PI
Diabetes Prevention Program Outcomes Study-Phase 2$491,520
U01 · FY2009 · DK · contact PI
Post-DPP Followup Studies$490,728
U01 · FY2008 · DK · contact PI
Post-DPP Followup Studies$254,655
U01 · FY2007 · DK · contact PI
Post-DPP Followup Studies$401,427
U01 · FY2006 · DK · contact PI
ACTOS NOW FOR PREVENTION OF DIABETES (ACT NOW)$125,373
M01 · FY2006 · RR · contact PI
DPPOS$83,582
M01 · FY2006 · RR · contact PI
ACTION FOR HEALTH IN DIABETES (LOOK AHEAD)$536,413
M01 · FY2005 · RR
Post-DPP Followup Studies$444,610
U01 · FY2005 · DK
DPPOS$92,666
M01 · FY2005 · RR
ACTOS NOW FOR PREVENTION OF DIABETES (ACT NOW)$72,142
M01 · FY2005 · RR
Action for Health in Diabetes (Look AHEAD)$758,148
M01 · FY2004 · RR
Post-DPP Followup Studies$445,760
U01 · FY2004 · DK
Diabetes Prevention Trial for Type II Diabetes (DPT-2)$71,297
M01 · FY2004 · RR
DPPOS$11,126
M01 · FY2004 · RR
Genomic and Proteomic Studies in Activated T-Lymphocytes and Muscle Tissue$3,860
M01 · FY2004 · RR
STUDY OF HEALTH OUTCOMES OF WEIGHT-LOSS (SHOW)$1,604,074
U01 · FY2003 · DK
Post-DPP Followup Studies$464,591
U01 · FY2003 · DK
STUDY OF HEALTH OUTCOMES OF WEIGHT-LOSS (SHOW)$7,300
U01 · FY2003 · DK
Clinical Center for Look AHEAD: Health in Diabetes$1,435,578
U01 · FY2002 · DK
DIABETES PREVENTION PROGRAM (DDP-2)$249,308
U01 · FY2002 · DK
Clinical Center for Look AHEAD: Health in Diabetes$7,150
U01 · FY2002 · DK
Clinical Center for Look AHEAD: Health in Diabetes$1,104,499
U01 · FY2001 · DK
DIABETES PREVENTION PROGRAM (DDP-2)$907,871
U01 · FY2001 · DK
MECHANISMS OF ACTION IN DPP INTERVENTIONS$501,325
R01 · FY2001 · DK
Clinical Center for Look AHEAD: Health in Diabetes$7,150
U01 · FY2001 · DK
SAFETY AND EFFICACY OF BRL49653C THERAPY IN NIDDM$0
M01 · FY2001 · RR
DIABETES PREVENTION TRIAL FOR TYPE II DIABETES (DDT 2)$0
M01 · FY2001 · RR
DHEA IN PREMENOPAUSAL AFRICAN AMERICAN VS CAUCASIAN AMERICANS$0
M01 · FY2001 · RR
Clinical Center for Look AHEAD: Health in Diabetes$983,136
U01 · FY2000 · DK
DIABETES PREVENTION PROGRAM (DDP-2)$841,221
U01 · FY2000 · DK
MECHANISMS OF ACTION IN DPP INTERVENTIONS$486,720
R01 · FY2000 · DK
DIABETES PREVENTION TRIAL FOR TYPE II DIABETES (DDT 2)$16,342
M01 · FY2000 · RR
DHEA IN PREMENOPAUSAL AFRICAN AMERICAN VS CAUCASIAN AMERICANS$16,342
M01 · FY2000 · RR
SAFETY AND EFFICACY OF BRL49653C THERAPY IN NIDDM$16,342
M01 · FY2000 · RR